AD
Aalok Dilip Shanghvi
About Aalok Dilip Shanghvi
Data last updated:
Aalok Dilip Shanghvi is a Whole-Time Director at Sun Pharmaceutical Industries Limited (since 2023) and Director at Shikha Learning Labs Private Limited (since 2024). The companies operate in Pharma, Energy and Power and Environment. The largest current company by reported revenue is Sun Pharmaceutical Industries Limited at ₹60,434 Cr (FY 2026). Earlier, Aalok Dilip Shanghvi was a Designated Partner at Solar Power Technologies India Llp (2010–2025) and Director at Pv Power Technologies Private Limited (2008–2023) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Pharmaceutical Industries Limited L24230GJ1993PLC019050 | Whole-Time Director | 01 Jun 2023 | 1993 | ₹60,434 Cr (FY 2026) | Active |
 Shikha Learning Labs Private Limited U62011MH2024PTC419664 | Director | 20 Feb 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Solar Power Technologies India Llp AAA-2389 | Designated Partner | 28 Sep 2010 | 2010 | Active | |
 Pv Power Technologies Private Limited U35105MH2008PTC178125 | Director | 22 Jan 2008 | 2008 | ₹190 Cr (FY 2025) | Active |
| Caraco Pharmaceuticals Private Limited U24100MH2012FTC225970 | Director | 12 Jan 2012 | 2012 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aalok Dilip Shanghvi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Andreas Eugen Busch | 11699735 | Sun Pharmaceutical Industries Limited | Director |
| Anoop Anjanikumar Deshpande | Sun Pharmaceutical Industries Limited | Company Secretary | |
| Dilip Shantilal Shanghvi | 00005588 | Sun Pharmaceutical Industries Limited | Whole-Time Director |
| Jayashree Satagopan | Sun Pharmaceutical Industries Limited | Cfo | |
| Kirti Wardhaman Ganorkar | 10620142 | Sun Pharmaceutical Industries Limited | Managing Director |
| Pawan Kumar Goenka | 00254502 | Sun Pharmaceutical Industries Limited | Director |
| Rolf Karl Heinz Hoffmann | 10200311 | Sun Pharmaceutical Industries Limited | Director |
| Satyavati Berera | 05002709 | Sun Pharmaceutical Industries Limited | Director |
| Vidhi Dilip Shanghvi | 06497350 | Sun Pharmaceutical Industries Limited | Whole-Time Director |
| Karishma Aalok Shanghvi | 03546211 | Shikha Learning Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aalok Dilip Shanghvi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aalok Dilip Shanghvi
Aalok Dilip Shanghvi currently holds 2 directorships: Sun Pharmaceutical Industries Limited (Whole-Time Director, since 01 Jun 2023, revenue ₹60,434 Cr (FY 2026)); Shikha Learning Labs Private Limited (Director, since 20 Feb 2024).
Aalok Dilip Shanghvi was first appointed on 22 Jan 2008 as Director at Pv Power Technologies Private Limited. The most recent appointment on record is 20 Feb 2024 at Shikha Learning Labs Private Limited.
Aalok Dilip Shanghvi held 3 earlier board appointments: Solar Power Technologies India Llp (Designated Partner, 28 Sep 2010 to 05 Aug 2025); Pv Power Technologies Private Limited (Director, 22 Jan 2008 to 31 Jan 2023); Caraco Pharmaceuticals Private Limited (Director, 12 Jan 2012 to 07 Jul 2018).
The current boards of Aalok Dilip Shanghvi's companies include Andreas Eugen Busch (Sun Pharmaceutical Industries Limited), Anoop Anjanikumar Deshpande (Sun Pharmaceutical Industries Limited), Dilip Shantilal Shanghvi (Sun Pharmaceutical Industries Limited), Jayashree Satagopan (Sun Pharmaceutical Industries Limited), Kirti Wardhaman Ganorkar (Sun Pharmaceutical Industries Limited), Pawan Kumar Goenka (Sun Pharmaceutical Industries Limited), among others.